CP-20961 is primarily utilized in the field of medical research, particularly in studies related to cancer therapy. It has been investigated for its potential role in inhibiting specific enzymes or pathways that are crucial for the survival and proliferation of cancer cells. Researchers have explored its application in preclinical models to assess its efficacy and safety profile, aiming to develop novel therapeutic agents for treating various types of cancers. Additionally, CP-20961 has been studied for its potential use in combination therapies, where it may enhance the effects of other anticancer drugs, offering a more comprehensive approach to cancer treatment. Its role in modulating cellular processes makes it a valuable compound for advancing our understanding of cancer biology and developing targeted therapies.